MIM
TELA icon

MetLife Investment Management’s TELA Bio TELA Stock Holding History

MetLife Investment Management’s Portfolio TELA Stock Details TELA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-8,467
Closed -$67.7K – 2861
2023
Q3 		$67.7K Hold
8,467
– – ﹤0.01% 2776
2023
Q2 		$85.8K Buy
+8,467
New +$86.6K ﹤0.01% 2768

Other funds holding TELA

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

MetLife Investment Management's TELA Position: Q4 2023 in Review

MetLife Investment Management sold out of TELA Bio (TELA) in Q4 2023, closing a stake of 8,467 shares — an estimated $67.7K sold.

MetLife Investment Management first reported a position in TELA in Q2 2023 and held it in 2 quarters. The position peaked at $85.8K in Q2 2023. 60 funds tracked by Wall St. Rank hold TELA as of Q4 2023.

  • MetLife Investment Management reported no remaining TELA Bio position as of Q4 2023 after selling out during the quarter.
  • MetLife Investment Management sold 8,467 TELA Bio shares in Q4 2023, an estimated $67.7K.
  • MetLife Investment Management first reported a position in TELA Bio in Q2 2023 and held it in 2 quarters.
  • MetLife Investment Management's TELA Bio position peaked at $85.8K in Q2 2023.
  • 60 funds tracked by Wall St. Rank held TELA Bio as of Q4 2023.

Based on MetLife Investment Management's 13F filing for Q4 2023, filed 14 Feb 2024.